Search Results - helena+mora-jensen

2 Results Sort By:
Eeyarestatins: Novel Deubiquitination Inhibitors for the Treatment of Drug-Resistant Cancers
The ubiquitin-proteasome system has recently been recognized to play a central role in tumor biology. Bortezomib, an inhibitor of the chymotrypsin-like activity of the proteasome, has clinical activity in a variety of hematologic malignancies and is FDA approved for use in Multiple Myeloma and Mantle Cell Lymphoma. The present invention for the first...
Published: 10/28/2024   |   Inventor(s): Helena Mora-Jensen, Qiuyan Wang, Yihong Ye, Adrian Wiestner
Keywords(s): Active, Against, BBXXXX, Bortezomib, CANCER, CB5EXX, CB5XXX, CBXXXX, Cells, Chronic lymphocytic leukemia, COMPOSITION, CXXXXX, DB4AXX, DB4XXX, DBXXXX, Deubiquination, DXXXXX, Eeyarestatin, Hematologic, Highly, HIV AIDS - Therapeutics, Including, inhibitor, lymphoma, Mantle cell lymphoma, MULTIPLE MYELOMA, Proteasome, RESISTANT, That, tumor
Category(s): Collaboration Sought > Collaboration, Collaboration Sought > Licensing, TherapeuticArea > Infectious Disease, Application > Therapeutics, TherapeuticArea > Oncology
Advanced White Matter Fiber Tractography Using Non-Gaussian Diffusion MRI
Summary: A new white matter tractography method based on the dMRI technique of diffusional kurtosis imaging (DKI) has been developed. This method, known as DKI fiber tractography (DKI-FT), substantially improves upon the existing technique because of its ability to resolve intersecting fiber bundles. Moreover, since it is also easily implemented on...
Published: 9/18/2024   |   Inventor(s): Joseph Helpern, Ali Tabesh (deceased 9.1.14), Jens Jensen
Keywords(s):  
Category(s): Digital Health & Creative Works